JUSTIN ANDERSON: Open Payments
NPI 1023494135 · BAINBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 50 payments from 7 companies in 2025. Trend: 2023 $671 · 2024 $436 · 2025 $1,172
Food & beverage: $1,074Education: $98
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $281 |
| ABBVIE INC. | 17 | $267 |
| Neurocrine BioSciences, Inc. | 7 | $219 |
| Teva Pharmaceuticals USA, Inc. | 7 | $215 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, UZEDY, COBENFY, FANAPT, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
